Search results
FDA advisers consider MDMA therapy to treat PTSD
KCCI 8 Des Moines· 22 minutes agoA federal advisory committee meets on Tuesday to weigh the risks and benefits of using MDMA, commonly known as ecstasy, as a treatment for post-traumatic...
It’s zero hour for psychedelic medicine
Politico via Yahoo News· 19 minutes agoIn its 2023 trial, 71 percent of participants who received the combo therapy no longer met the criteria for PTSD. The FDA decision is a huge moment for ...
FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex
Pharmaceutical Technology via Yahoo Finance· 3 hours ago"We have initiated our pivotal Phase III NEAT clinical trial, which is being conducted in the US,...
FDA selects Larimar Therapeutics for new program inspired by Operation Warp Speed - The Business...
The Business Journals· 3 hours agoNomlabofusp, an experimental therapy for Friedreich’s ataxia being developed by Larimar Therapeutics, was chosen for the FDA's Support for Clinical Trials ...
FibroGen To Begin Trials on Tumor Treatment After FDA OK
Morningstar· 18 hours agoFibroGen can begin conducting clinical trials for its potential solid tumor treatment after regulators approved the company's application. The San Francisco-based company ...
BridgeBio posts BioMarin-beating data on dwarfism drug prospect
FierceBiotech· 3 hours agoBridgeBio Pharma has bounced back from the withdrawal of infigratinib in oncology, linking the...
Hansa completes randomisation in Phase III trial of imlifidase
Clinical Trials Arena via Yahoo Finance· 1 day agoHansa Biopharma is committed to further substantiating the clinical evidence of imlifidase through...
Walgreens will conduct clinical trials for Boehringer Ingelheim's new obesity drug
BenefitsPRO· 23 hours agoThe drugmaker is moving into Phase III studies for survodutide, which it is developing in...
FibroGen Stock Is Surging After The Bell: What's Going On? - FibroGen (NASDAQ:FGEN)
Benzinga· 18 hours agoThe company also announced a new clinical trial supply agreement with Regeneron. What Happened:...
Claims of Misconduct Mar MDMA Research for PTSD
High Times· 4 hours agoThe U.S. Food and Drug Administration is...Multidisciplinary Association for Psychedelic Studies (MAPS) and its public benefit Lykos, which has conducted clinical trials in ...
